Benzinga | May 13, 2021 04:29PM EDT

Co-Diagnostics Q1 EPS $0.26 Beats $0.22 Estimate, Sales $20.00M Beat $19.89M Estimate

Co-Diagnostics (NASDAQ:CODX) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.22 by 18.18 percent. This is a 620 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $20.00 million which beat the analyst consensus estimate of $19.89 million by 0.55 percent. This is a 1.19K percent increase over sales of $1.55 million the same period last year.